Research Areas

Today's research for tomorrow's
health breakthroughs

With more than 600 clinical trials completed over three decades, we've been the trusted choice for Phase 1-4 clinical trials involving thousands of participants. Our full-time, dedicated, board-certified investigators work with a team of clinical trial professionals in our state-of-the-art facility to complete studies in a wide range of therapeutic areas. 

Diabetes

Type 1 Diabetes

Medical Devices

High Cholesterol

Weight Loss

Type 2 Diabetes

Low Testosterone

NASH

Early Phase

Vaccines

Ophthalmology

Healthy Normal

Learn more about some of the studies we've completed in a wide range of therapeutic areas.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

A Phase 1, Open-Label, Dose-Escalation Study of the Safety and Immunogenicity of An Investigational Vaccie for SARS-COV-2 Targeting A Variant Spike Protein in Unvaccinated or Previously Vaccinated Healthy Adults

Vaccine

A Phase 2/3 Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of An Investigational Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 60 Years and Older

A Phase 3 Parallel Design, Open Label, Randomized Controlled Study to Evaluate the Efficacy and Safety of An Investigational Weekly Insulin Compared to a Marketed Insulin in Adults with Type II Diabetes on Multiple Daily Injections

Type II Diabetes

A Phase 3, Multicenter, Randomized, Parallel Design, Open Label Study to Evaluate the Efficacy and Safety of An Investigational Weekly Insulin Compared with A Marketing Insulin in Participants With Type I Diabetes Treated with Multiple Daily Injection Therapy

Type I Diabetes

A Phase 1b Study of An Investigational Medication in Patients With Type I Diabetes

Type I Diabetes

A Multicenter, Randomized, Double-Blind, Crossover, Phase 2 Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy with An Investigational Medication Compared to Levothyroxine in Patients With Primary Hypothyroidism

Hypothyroid

A Comparator Study of Hemoglobin A1c Samples Collected Using an Investigational Blood Collection Device

Devices Technology

Accuracy Study off An Interstitial Fluid Glucose Sensor

Devices Technology

Clinical Evaluation of the Glucose Test in Capillary Specimens Using An Investigational Analyzer

Devices Technology

Safety Evaluation of An Investigational Closed Loop System in Type 1 Adult and Pediatric Subjects Utilizing An Approved Short Acting Insulin

Devices Technology

Evaluation of An Investigational Closed Loop Insulin Delivery System in Type 1 Adult and Pediatric Subjects using an Approved Insulin

Devices Technology

An In-Home Study with An Investigational Insulin Delivery System in Subjects with Adult Type 2 Diabetes Who Are Insulin Requiring

Devices Technology

Characterization Study of An Investigational Glucose Monitoring System Using Capillary Glucose Reference

Devices Technology

A Pilot Study of the Feasibility and Accuracy of An Investigational Continuous Glucose Monitoring System

Devices Technology

Evaluation of a Sensor for Continuous Glucose Monitoring of Glucose Levels Within the Interstitial Fluid over a 14-Day Wearing Period

Devices Technology

Method Comparison/User Evaluation of An Investigational Self-Monitoring Blood Glucose System

Devices Technology

An Early Feasibility Study to Evaluate the Safety and Functionality of an Individual Accruing Data Algorithm with An Investigational Medication in Adult Participants with Type 2 Diabetes

Type II Diabetes

A Phase 3 Multicenter Randomized Parallel Design, Open Label Trial to Evaluate the Efficacy and Safety of An Investigational Medication Compared to An Approved Insulin in Participants with Type 2 Diabetes Currently Treated with Basal Insulin

Type II Diabetes

A 52-Week Study Comparing the Efficacy and Safety of A Once Weekly Investigational Medication and Daily Insulin Glargine Combined with Insulin Aspart, Both Treatment Arms With or Without Oral Anti-Diabetic Drugs in Participants With Type 2 Diabetes Inadequately Controlled With Daily Basal Insulin

Type II Diabetes

Precision Study of in An Investigational Point of Care Device Using Whole Blood

Devices Technology

Volunteer to participate in a study

See current studies
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.